Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cost of Revenue: 2010-2012

Historic Cost of Revenue for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to $1.1 million.

  • Sonoma Pharmaceuticals' Cost of Revenue rose 13.97% to $1.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $4.8 million, marking a year-over-year increase of 32.91%. This contributed to the annual value of $4.0 million for FY2012, which is 11.54% up from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Cost of Revenue of $1.1 million as of Q4 2012, which was down 19.38% from $1.3 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Cost of Revenue registered a high of $1.3 million during Q3 2012, and its lowest value of $781,000 during Q1 2011.
  • Moreover, its 3-year median value for Cost of Revenue was $991,000 (2011), whereas its average is $1.0 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first dropped by 19.42% in 2011, then skyrocketed by 55.70% in 2012.
  • Sonoma Pharmaceuticals' Cost of Revenue (Quarterly) stood at $1.2 million in 2010, then decreased by 19.42% to $938,000 in 2011, then climbed by 13.97% to $1.1 million in 2012.
  • Its Cost of Revenue stands at $1.1 million for Q4 2012, versus $1.3 million for Q3 2012 and $1.2 million for Q2 2012.